Publicaciones en las que colabora con María José Torres Jaén (25)

2021

  1. Aradyal: The spanish multidisciplinary research network for allergic diseases

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119

  2. Diagnostic Approach of Hypersensitivity Reactions to Cefazolin in a Large Prospective Cohort

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 12, pp. 4421-4430.e4

  3. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity

    British Journal of Dermatology, Vol. 185, Núm. 4, pp. 815-824

  4. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 5, pp. 1325-1339

2020

  1. Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 8, pp. 2707-2714.e2

  2. Design of an antigenic determinant of cefaclor: Chemical structure–IgE recognition relationship

    Journal of Allergy and Clinical Immunology, Vol. 145, Núm. 4, pp. 1301-1304.e4

  3. Hypersensitivity Reactions to Multiple Iodinated Contrast Media

    Frontiers in Pharmacology, Vol. 11

  4. Medical algorithm: Diagnosis and treatment of nonsteroidal antiinflammatory drugs hypersensitivity

    Allergy: European Journal of Allergy and Clinical Immunology

  5. Precision medicine in house dust mite-driven allergic asthma

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-18

  6. Reply

    Journal of Allergy and Clinical Immunology

2019

  1. Accuracy of the diagnosis of allergic reactions in the emergency department

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 3, pp. 222-230

  2. Diagnostic Approximation to Delabeling Beta-Lactam Allergic Patients

    Current Treatment Options in Allergy, Vol. 6, Núm. 1, pp. 56-70

  3. Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions

    Current Treatment Options in Allergy, Vol. 6, Núm. 1

  4. Polymorphisms in CEP68 gene associated with risk of immediate selective reactions to non-steroidal anti-inflammatory drugs

    Pharmacogenomics Journal, Vol. 19, Núm. 2, pp. 191-199

  5. Recent developments and highlights in drug hypersensitivity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 12, pp. 2368-2381

2018

  1. An EAACI task force report: Recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity

    Clinical and Translational Allergy, Vol. 8, Núm. 1

  2. Penicillin and Cephalosporin-Induced Anaphylaxis: an Update

    Current Treatment Options in Allergy, Vol. 5, Núm. 2, pp. 188-203

  3. Practical guidelines for perioperative hypersensitivity reactions

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 4, pp. 216-232

2017

  1. Evolution of diagnostic approaches in betalactam hypersensitivity

    Expert Review of Clinical Pharmacology, Vol. 10, Núm. 6, pp. 671-683

  2. Response to Ebo et al., Letter to the Editor Regarding Update on Quinolone Allergy

    Current Allergy and Asthma Reports, Vol. 17, Núm. 10